Pouch Labeling (51662 1558 2 Pouch Label)
Prochlorperazine Edisylate Injection
Product Images NDC 51662-1558
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 51662-1558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Case Labeling (51662 1558 3 Case Labeling)
Rfid Labeling (51662 1558 3 Rfid Label)
Boxed Warning (Boxed Warning)
The text describes a warning about the use of antipsychotic drugs in elderly patients with dementia-related psychosis. Such patients treated with these drugs are at higher risk of death due to cardiovascular and infectious causes. The risk of death is higher in those taking atypical antipsychotic drugs than in those taking a placebo. The extent to which the risk is caused by the drug or patient characteristics is not clear. The warning states that the use of Prochlorperazine Edisylate Injection, USP is not approved for such patients.*
Structure (Structure)
Vial Label (Vial Label)
This is a label for a medication with the NDC code 23155-294-31. It advises that the medication should be protected from light. The medication is Prochlorperazine with a manufacturing license number G/28/1655. The medication is manufactured by Emcure Pharmaceuticals Ltd. in Sanand, Ahmedabad, with a concentration of 10 mg/2 mL. The medication is not for subcutaneous use and comes in a 2 mL multiple-dose vial, available by prescription only from Avet Pharma.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
